IGC Pharma (IGC) Institutional Ownership $0.31 -0.02 (-6.16%) Closing price 05/1/2025 03:57 PM EasternExtended Trading$0.31 0.00 (0.00%) As of 05/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipSEC FilingsBuy This Stock Institutional Ownership Changes (13F Filings) for IGC Pharma (NYSEMKT:IGC)CurrentInstitutional OwnershipPercentage3.87%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$228.71KNumber ofInstitutional Sellers(last 12 months)0 Get IGC Insider Trade Alerts Want to know when executives and insiders are buying or selling IGC Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IGC Institutional Buying and Selling by Quarter IGC Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Squarepoint Ops LLC125,966$42K0.0%N/A0.163% 2/14/2025Northern Trust Corp113,407$38K0.0%+59.7%0.146% 2/12/2025Geode Capital Management LLC669,685$225K0.0%+19.0%0.865% 11/20/2024Virtu Financial LLC123,060$53K0.0%+164.7%0.159% 11/16/2024Geode Capital Management LLC562,969$240K0.0%+31.0%0.744% 10/29/2024 Fullcircle Wealth LLC103,443$42K0.0%N/A0.137% (Data available from 1/1/2016 forward) IGC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IGC shares? During the previous two years, the following institutional investors and hedge funds held shares of IGC Pharma shares: Geode Capital Management LLC ($225K), Virtu Financial LLC ($53K), Squarepoint Ops LLC ($42K), and Fullcircle Wealth LLC ($42K), Northern Trust Corp ($38K).Learn more on IGC's institutional investors. What percentage of IGC Pharma stock is owned by institutional investors? 3.87% of IGC Pharma stock is owned by institutional investors. Learn more on IGC's institutional investor holdings. Which institutional investors have been buying IGC Pharma stock? The following institutional investors have purchased IGC Pharma stock in the last 24 months: Geode Capital Management LLC ($239.86K), Squarepoint Ops LLC ($125.97K), Fullcircle Wealth LLC ($103.44K), Virtu Financial LLC ($76.56K), and Northern Trust Corp ($42.38K). How much institutional buying is happening at IGC Pharma? Institutional investors have bought a total of 588,210 shares in the last 24 months. This purchase volume represents approximately $228.71K in transactions. Related Companies Lineage Cell Therapeutics Institutional Ownership MacroGenics Institutional Ownership Galectin Therapeutics Institutional Ownership Anixa Biosciences Institutional Ownership TScan Therapeutics Institutional Ownership Kyverna Therapeutics Institutional Ownership Vor Biopharma Institutional Ownership Black Diamond Therapeutics Institutional Ownership Entera Bio Institutional Ownership HilleVax Institutional Ownership This page (NYSEMKT:IGC) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGC Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGC Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.